Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. Ozempic and Rybelsus helped Novo gain share over Eli Lilly's once-weekly ...

Sen. Mike Braun has a unique opportunity to hold Novo Nordisk accountable for discontinuing insulin drug Levemir.

Novo Nordisk will meet with U.S. Senate aides to discuss the discontinuation of Levemir, its long-acting insulin, amid concerns about manufacturing constraints and patient access. Senators press ...

Novo Nordisk Under Scrutiny for Stopping Sales of Levemir Insulin in the US US Senate Democrats will meet with Novo Nordisk executives to address the fallout from its decision to stop selling one ...

After discontinuing its long-acting insulin product Levemir, Novo has again found itself under legislative scrutiny, with three Democratic senators seeking a sit-down with the pharma.

The Novo spokesperson said in a statement to Reuters on Friday that Levemir was not discontinued due to "success" of the company's newer medicines Wegovy and Ozempic, widely prescribed for weight loss ...

Meetings between Congressional aides and company representatives are routine. The Novo spokesperson said in a statement to Reuters on Friday that Levemir was not discontinued due to "success" of the ...

Novo Nordisk will meet with the aides for Senators Jeanne Shaheen, Raphael Warnock, and Elizabeth Warren. In April, the lawmakers wrote to the company expressing alarm at its decision, announced in ...

The Novo spokesperson said in a statement to Reuters on Friday that Levemir was not discontinued due to "success" of the company's newer medicines Wegovy and Ozempic, widely prescribed for weight ...